2025/03/03 by Rebecca S. Saleeb, Judi O’Shaughnessy, Ryan Ferguson +2 · 1 voice · 1 citation
Biochemistry, Genetics and Molecular Biology · Chemistry · Medicine · #Advanced Biosensing Techniques and Applications #Advanced biosensing and bioanalysis techniques #Biology #Chemistry #Computational biology #Computer science #Materials science #Monoclonal and Polyclonal Antibodies Research #Multiplexing #Nanotechnology #Telecommunications
paper · pdf · doi:10.1101/2025.02.28.640765
openalex publication_date 2025/03/03 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/14
Abstract Recently developed secondary nanobodies or single-domain antibodies present a powerful tool for immunodetection. Unlike traditional antibodies, their monovalence enables pre-association with primary antibodies prior to sample staining, presenting a straightforward affinity-based antibody labeling solution. This not only simplifies and streamlines immunoassays, it also supports multiplexed techniques where conflicts in the species of the desired primary antibodies preclude standard indirect immunostaining. Despite these advantages, the use of secondary nanobodies remains sparse, due perhaps to a lack of evaluation on their suitability for assays requiring quantification and an assessment of optimal protocols for their use. Here, we present a set of experiments spanning single-molecule detection to cell imaging that can be used to validate secondary nanobody binding, specificity, and their propensity for mis-targeted binding in multiplex assays. Using these tools, we analyzed the binding properties of commercially available secondary nanobodies and outline optimized protocols for their robust use.